...
首页> 外文期刊>Arthritis & Rheumatism >Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: Data from the étude et Suivi des Polyarthrites IndifféRenciées récentes (Study and Followup of Early Undifferentiated Polyarthritis)
【24h】

Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: Data from the étude et Suivi des Polyarthrites IndifféRenciées récentes (Study and Followup of Early Undifferentiated Polyarthritis)

机译:早期疾病抗风湿药治疗对早期炎性关节炎的放射学进展的有利影响:Étudeet Suivi des PolyarthritesIndifféRenciéescentcentes的数据(早期未分化多关节炎的研究和随访)

获取原文
获取原文并翻译 | 示例
           

摘要

While there is consensus that treatment with disease-modifying antirheumatic drugs (DMARDs) should be started early in patients with inflammatory arthritis, confirmation that radiographic progression is inhibited with early treatment start is scarce. This study was undertaken to compare radiographic progression in patients treated with a DMARD very early in the course of their disease (within 3 months of diagnosis) and those who began DMARD treatment later.
机译:尽管人们普遍认为应在炎症性关节炎患者中尽早使用改变疾病的抗风湿药(DMARDs)治疗,但确认早期治疗开始会抑制影像学进展。进行这项研究的目的是比较在疾病早期(诊断后3个月内)接受DMARD治疗的患者与后来接受DMARD治疗的患者的放射学进展。

著录项

  • 来源
    《Arthritis & Rheumatism》 |2011年第7期|1804-1811|共8页
  • 作者单位

    Lapeyronie Hospital Montpellier France;

    Bichat Hospital Paris France;

    Hautepierre Hospital Strasbourg France;

    University Hospital Maastricht Maastricht The Netherlands;

    Leiden University Medical Center Leiden The Netherlands;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号